1-8 of 8
Xiang Liu
Close
Sort by
Journal Articles

The Important Role of Egfr Change in Patients with Multiple Myeloma

Xiang Liu, Wenjiao Tang, Ting Niu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6653.
https://doi.org/10.1182/blood-2023-189743
Published: 2023
Journal Articles

Hepatitis B Virus Infection Status and Reactivation Analysis in Multiple Myeloma in China

Wenjiao Tang, Xiang Liu, Yan Li, Li Zhang, Ting Niu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6645.
https://doi.org/10.1182/blood-2023-186011
Published: 2023
Journal Articles

Population Pharmacokinetics of Ruxolitinib in Patients with aGVHD Who Had an Inadequate Response to Corticosteroids

Xuejun Chen, Xiang Liu, Phillip Wang, Swamy Yeleswaram, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4534.
https://doi.org/10.1182/blood-2019-124027
Published: 2019
Journal Articles

Research of miR-30b in Cisplatin Resistance of Human NK/T Cell Lymphoma Lines SNK-6 and YTS Cells By Targeting CCL22

Rong Liang, MD PhD, Jian hong Wang, MD, Fang Liu, MD, Xiao hui Duan, MD, Xia Cai Hao, MD, Liang Zhang, MD PhD, Michael Wang, MD, Xiang -xiang Liu, MD, Yan Hua Guo, MD, Zhe Wang, PhD, Hailong Tang, PhD, Ljie Yang, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5302.
https://doi.org/10.1182/blood-2018-99-114405
Published: 2018
Journal Articles

H3B-8800, an Orally Bioavailable Modulator of the SF3b Complex, Shows Efficacy in Spliceosome-Mutant Myeloid Malignancies

Silvia Buonamici, PhD, Akihide Yoshimi, MD PhD, Michael Thomas, Michael Seiler, PhD, Betty Chan, PhD, Benjamin Caleb, Rachel Darman, PhD, Peter Fekkes, PhD, Craig Karr, PhD, Gregg F. Keaney, PhD, Virginia M. Klimek, MD, Kaiko Kunii, Linda Lee, Stanley Chun-Wei Lee, PhD, Xiang Liu, PhD, Carol Meeske, Yoshiharu Mizui, PhD, Eric Padron, MD, Eunice Park, PhD, Ermira Pazolli, PhD, Sudeep Prajapati, PhD, Justin Taylor, MD, John Wang, PhD, Markus Warmuth, MD, Lihua Yu, PhD, Ping Zhu, MD, Omar Abdel-Wahab, MD, Peter G Smith, PhD
Journal: Blood
Blood (2016) 128 (22): 966.
https://doi.org/10.1182/blood.V128.22.966.966
Published: 2016
Journal Articles

Arsenic Sulfide Binds c-CBL to Promote BCR-ABL Ubiquitination and Degradation In Chronic Myelogenous Leukemia.

Jian-Hua Mao, Xiao-Yan Sun, Jian-Xiang Liu, Qun-Ye Zhang, Ping Liu, Qiu-Hua Huang, Ke-Qin Li, Xiao-Wei Zhang, Quan Chen, Zhu Chen, Sai-Juan Chen
Journal: Blood
Blood (2010) 116 (21): 1200.
https://doi.org/10.1182/blood.V116.21.1200.1200
Published: 2010
Journal Articles

The soluble murine type I interferon receptor Ifnar-2 is present in serum, is independently regulated, and has both agonistic and antagonistic properties

Matthew P. Hardy, Catherine M. Owczarek, Suzana Trajanovska, Xiang Liu, Ismail Kola, Paul J. Hertzog
Journal: Blood
Blood (2001) 97 (2): 473–482.
https://doi.org/10.1182/blood.V97.2.473
Published: 2001
Journal Articles

Studies on Treatment of Acute Promyelocytic Leukemia With Arsenic Trioxide: Remission Induction, Follow-Up, and Molecular Monitoring in 11 Newly Diagnosed and 47 Relapsed Acute Promyelocytic Leukemia Patients

Chao Niu, Hua Yan, Ting Yu, Hui-Ping Sun, Jian-Xiang Liu, Xiu-Song Li, Wen Wu, Fen-Qin Zhang, Yu Chen, Li Zhou, Jun-Min Li, Xiao-Ying Zeng, Ren-Rong Ou Yang, Mi-Man Yuan, Mei-Yu Ren, Feng-Ying Gu, Qi Cao, Bo-Wei Gu, Xin-Ying Su, Guo-Qiang Chen, Shu-Min Xiong, Ting-dong Zhang, Samuel Waxman, Zhen-Yi Wang, Zhu Chen, Jiong Hu, Zhi-Xiang Shen, Sai-Juan Chen
Journal: Blood
Blood (1999) 94 (10): 3315–3324.
https://doi.org/10.1182/blood.V94.10.3315.422k16_3315_3324
Published: 1999